Clinical Trial Update: AMIloride for the Treatment of Nephrogenic Diabetes Insipidus for Patients With Bipolar Disorder Treated With Lithium [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating amiloride for nephrogenic diabetes insipidus in patients with bipolar disorder treated with lithium; trial is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Nephrogenic Diabetes Insipidus

Drugs mentioned

• Amiloride (amiloride)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Bipolar Disorder | Phase 4 | Status: ACTIVE_NOT_RECRUITING